Heart Failure in Adult Congenital Heart Disease. Nonpharmacologic Treatment Strategies.

Lisa LeMond, Tuan Mai, Craig Broberg, Ashok Muralidaran, Luke Burchill

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    In early stages, heart failure (HF) in adult congenital heart disease (ACHD) remains an elusive diagnosis. Many ACHD patients seem well-compensated owing to chronic physical and psychological adaptations. HF biomarkers and cardiopulmonary exercise tests are often markedly abnormal, although patients report stable health and good quality of life. Treatment differs from acquired HF. Evidence for effective drug therapy in ACHD-related HF is lacking. Residual ventricular, valvular, and vascular abnormalities contribute to HF pathophysiology, leading to an emphasis on nonpharmacologic treatment strategies. This article reviews emerging perspectives on nonpharmacologic treatment strategies, including catheter-based interventions, surgical correction, and palliative care.

    Original languageEnglish (US)
    Pages (from-to)589-598
    Number of pages10
    JournalCardiology Clinics
    Volume33
    Issue number4
    DOIs
    StatePublished - Nov 1 2015

    Fingerprint

    Heart Diseases
    Heart Failure
    Therapeutics
    Psychological Adaptation
    Palliative Care
    Exercise Test
    Blood Vessels
    Catheters
    Biomarkers
    Quality of Life
    Drug Therapy
    Health

    Keywords

    • Adult congenital heart disease
    • Arrhythmia
    • Biomarkers
    • Cardiac surgery
    • Heart failure
    • Structural intervention

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this

    Heart Failure in Adult Congenital Heart Disease. Nonpharmacologic Treatment Strategies. / LeMond, Lisa; Mai, Tuan; Broberg, Craig; Muralidaran, Ashok; Burchill, Luke.

    In: Cardiology Clinics, Vol. 33, No. 4, 01.11.2015, p. 589-598.

    Research output: Contribution to journalArticle

    @article{d46bd225d84a49e78453571def3e7513,
    title = "Heart Failure in Adult Congenital Heart Disease. Nonpharmacologic Treatment Strategies.",
    abstract = "In early stages, heart failure (HF) in adult congenital heart disease (ACHD) remains an elusive diagnosis. Many ACHD patients seem well-compensated owing to chronic physical and psychological adaptations. HF biomarkers and cardiopulmonary exercise tests are often markedly abnormal, although patients report stable health and good quality of life. Treatment differs from acquired HF. Evidence for effective drug therapy in ACHD-related HF is lacking. Residual ventricular, valvular, and vascular abnormalities contribute to HF pathophysiology, leading to an emphasis on nonpharmacologic treatment strategies. This article reviews emerging perspectives on nonpharmacologic treatment strategies, including catheter-based interventions, surgical correction, and palliative care.",
    keywords = "Adult congenital heart disease, Arrhythmia, Biomarkers, Cardiac surgery, Heart failure, Structural intervention",
    author = "Lisa LeMond and Tuan Mai and Craig Broberg and Ashok Muralidaran and Luke Burchill",
    year = "2015",
    month = "11",
    day = "1",
    doi = "10.1016/j.ccl.2015.07.004",
    language = "English (US)",
    volume = "33",
    pages = "589--598",
    journal = "Cardiology Clinics",
    issn = "0733-8651",
    publisher = "W.B. Saunders Ltd",
    number = "4",

    }

    TY - JOUR

    T1 - Heart Failure in Adult Congenital Heart Disease. Nonpharmacologic Treatment Strategies.

    AU - LeMond, Lisa

    AU - Mai, Tuan

    AU - Broberg, Craig

    AU - Muralidaran, Ashok

    AU - Burchill, Luke

    PY - 2015/11/1

    Y1 - 2015/11/1

    N2 - In early stages, heart failure (HF) in adult congenital heart disease (ACHD) remains an elusive diagnosis. Many ACHD patients seem well-compensated owing to chronic physical and psychological adaptations. HF biomarkers and cardiopulmonary exercise tests are often markedly abnormal, although patients report stable health and good quality of life. Treatment differs from acquired HF. Evidence for effective drug therapy in ACHD-related HF is lacking. Residual ventricular, valvular, and vascular abnormalities contribute to HF pathophysiology, leading to an emphasis on nonpharmacologic treatment strategies. This article reviews emerging perspectives on nonpharmacologic treatment strategies, including catheter-based interventions, surgical correction, and palliative care.

    AB - In early stages, heart failure (HF) in adult congenital heart disease (ACHD) remains an elusive diagnosis. Many ACHD patients seem well-compensated owing to chronic physical and psychological adaptations. HF biomarkers and cardiopulmonary exercise tests are often markedly abnormal, although patients report stable health and good quality of life. Treatment differs from acquired HF. Evidence for effective drug therapy in ACHD-related HF is lacking. Residual ventricular, valvular, and vascular abnormalities contribute to HF pathophysiology, leading to an emphasis on nonpharmacologic treatment strategies. This article reviews emerging perspectives on nonpharmacologic treatment strategies, including catheter-based interventions, surgical correction, and palliative care.

    KW - Adult congenital heart disease

    KW - Arrhythmia

    KW - Biomarkers

    KW - Cardiac surgery

    KW - Heart failure

    KW - Structural intervention

    UR - http://www.scopus.com/inward/record.url?scp=84945294766&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84945294766&partnerID=8YFLogxK

    U2 - 10.1016/j.ccl.2015.07.004

    DO - 10.1016/j.ccl.2015.07.004

    M3 - Article

    VL - 33

    SP - 589

    EP - 598

    JO - Cardiology Clinics

    JF - Cardiology Clinics

    SN - 0733-8651

    IS - 4

    ER -